Contineum Therapeutics Inc (CTNM)
NASDAQ
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Return on Assets (%) | 34.85 |
Return on Equity (%) | -66.886 |
Return on Invested Capital (%) | 25.418 |
Operating Margin (%) | 46.756 |
Net Profit Margin (%) | 45.44 |
Book Value Per Share | 1.22 |
Earnings Per Share | 0.222 |
Cash Per Share | 0.152 |
Working Capital Per Share | 1.196 |
Operating Profit Per Share | 0.489 |
EBIT Per Share | 0.227 |
EBITDA Per Share | 0.227 |
Free Cash Flow Per Share | 0.224 |
Year End December 30 2023 | 2023 |
---|---|
Current Ratio | N/A |
Quick Ratio | N/A |
Inventory Turnover (Days) | N/A |
Shares Outstanding | 13.15M |
Year End December 30 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
---|---|---|---|
USD ($) | |||
Shares Outstanding | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A |
Quick Ratio | N/A | N/A | N/A |
Inventory Turnover (Days) | N/A | N/A | N/A |
Market Cap | 364.5M |
Price to Earnings Ratio | 16.35 |
Price to Sales Ratio | 7.43 |
Price to Cash Ratio | 23.92 |
Price to Book Ratio | 2.98 |
Dividend Yield | - |
Shares Outstanding | 25.78M |
Average Volume (1 week) | 283.94k |
Average Volume (1 Month) | 131.31k |
52 Week Change | -0.62% |
52 Week High | 22.00 |
52 Week Low | 12.33 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.